Astellas Pharma (ADR)
- Market cap
- 25.68B
- P/E (TTM)i
- 13.19
- P/Bi
- 2.08
- EPSi
- 1.08
- Div yieldi
- 3.48%
- 52W posi
- 58%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Astellas Pharma (ADR) closed at 14.24, up 0.64%. That leaves the company valued at approximately 25.68B, the #770 most valuable US-listed company we track. The stock also carries a trailing dividend yield of 3.48%. The shares sit 58% of the way up their 52-week range of 10.03 to 17.35.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 1 week.
- Its last 3 Sell calls were followed by roughly flat moves (+1%) three months out.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 14.15
- Open
- 13.81
- Day range
- 13.81 - 14.27
- Avg price
- --
- Volume
- 7.34K
- Turnover
- 104.58K
- Turnover ratei
- 0.00%
- Amplitudei
- 3.25%
- 52-week rangei
- 10.03 - 17.35
Valuation
- P/Ei
- --
- P/E (TTM)i
- 13.19
- P/Bi
- 2.08
- EPSi
- 1.08
- Book value / shi
- 6.84
- Net profit
- --
- Net assets
- --
Share structure
- Market cap
- 25.68B
- Float capi
- --
- Shares out
- 1.80B
- Float sharesi
- 1.80B
Dividend & listing
- Div yield (TTM)i
- 3.48%
- Dividend (TTM)
- 0.49
- Listing date
- 1970-01-01
17.9% below the 52-week high
Frequently asked questions
What is the current stock price of Astellas Pharma (ADR) (ALPMY)?
Astellas Pharma (ADR) last traded at 14.24. The quote on this page refreshes every few seconds while US markets are open.
What is Astellas Pharma (ADR)'s market cap?
About 25.68B.
What is the P/E ratio of Astellas Pharma (ADR)?
The trailing twelve-month P/E is 13.19. The Valuation tab shows it against the stock's own five-year range.
Does Astellas Pharma (ADR) pay a dividend?
Yes. The trailing dividend yield is 3.48%. See the Dividends tab for the full payment history.
What is Astellas Pharma (ADR)'s StockVane Quant Rating?
The StockVane Momentum strategy currently rates Astellas Pharma (ADR) a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 19:00:41 · For reference only, not investment advice and not tailored to your situation.